Search

Retinitis pigmentosa (RP) is the most common inherited retinal disease. Even though more than 1.5 million people worldwide are affected, there is no cure and treatment options are limited. (1) [...]

A recurring feature at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in Boston, Massachusetts, was the call for environmentally friendly practices worldwide, with the goal [...]

Patients are currently diagnosed with keratoconus based on the results of pachymetry, topography, or tomography. Researchers from the University of Pittsburgh in Pennsylvania propose that corneal wavefront analysis may be [...]

Nanoscale extracellular vesicles (EVs) that include exomers, exosomes, and microvesicles/ectosomes are thought to have a future in the treatment of degenerative retinal diseases, (1) according to a team of European [...]

Latanoprostene bunod 0.024% (LBN) (Vyzulta, Bausch & Lomb), a prostaglandin analogue (PGA), received FDA approval in 2017 based on data obtained in 2 prospective randomized clinical trials of 840 patients [...]

A recent study conducted by US and Australian researchers found that a deep learning model for an artificial intelligence (Al)-assisted approach for detecting nascent geographic atrophy (GA) has the future [...]

David Eichenbaum, MD, from Retina Vitreous Associates of Florida and the Morsani College of Medicine at the University of South Florida, Tampa, discussed challenging cases of neovascular age-related macular degeneration [...]

Ben Gaddie, OD, FAAO, discussed the highlights of a recent roundtable discussion regarding 2 cases of patients with Demodex blepharitis--related ocular surface disease. He is in private practice at Gaddie [...]

During a recent Ophthalmology Times Case-Based Roundtable discussion, Albert S. Khouri, MD, professor of ophthalmology at Rutgers New Jersey Medical School in Newark, shared his pearls in proactive glaucoma management. [...]

Documenting the visual effects and simplifying visual life. Reviewed by Lotfi Merabet, OD, PhD, MPH Cerebral (or cortical) visual impairment (CVI), the most common cause of visual impairment in pediatric [...]

Dilsher S. Dhoot, MD, a clinician from California Retina Consultants in Santa Barbara, recently moderated a roundtable discussion on biosimilars for Ophthalmology Times. Because of the newness of the use [...]

Diagnosing inherited retinal diseases (IRDs) poses a challenge to clinicians because of their genetic and clinical heterogeneity. Technological advances in optical coherence tomography (OCT) and fundus autofluorescence facilitate detection of [...]

Cerebral (or cortical) visual impairment (CVI), the most common cause of visual impairment in pediatric patients in developed countries, (1) is the umbrella term for brain-based visual disorders that damage [...]

The American Society of Cataract and Refractive Surgery (ASCRS) will hit a historic landmark, the 50th anniversary of the organization, in a historic setting. Anterior segment surgeons are invited to [...]

David Eichenbaum, MD, discussed the status of the technology at the Retina 2024 meeting in Maui. Ocular gene therapy is not yet ready for prime time, according to David Eichenbaum, [...]

Recent advances have moved the needle forward in the treatment of geographic atrophy (GA). However, more work is needed to determine which patients and lesions will benefit most from new [...]

The first step in management is increasing the time spent outside Pediatric ophthalmologist Noha Ekdawi, MD, FAAP, shares 2 cases of myopia management in children and highlights her treatment approach [...]

Neurotrophic keratopathy (NK) is best treated early, but when that is not the case there are several surgical approaches that can be used. Clara Chan, MD, from the University of [...]

Premium IOLs have a lot to offer patients; however, added costs and time spent educating patients are considerations for clinicians. Sharon Richens, MD, FACS, shares the highlights from a recent [...]

Diagnosing inherited retinal diseases (IRDs) is not for the faint of heart. Diagnosticians face a number of challenges, according to Ishrat Ahmed, MD, PhD, who discussed this topic recently at [...]

Sunil Srivastava, MD, a uveitis and retina specialist at Cleveland Clinic in Ohio, shared valuable insights from a recent roundtable discussion on managing chronic noninfectious uveitis and macular edema (ME) [...]

Two retina specialists participated in an Ophthalmology Times case-based roundtable discussion and shared their experiences using the 2 FDA-approved anti-VEGF biosimilars, ranibizumab-eqrn (Cimerli; Coherus BioSciences) and ranibizumab-nuna (Byooviz; Biogen) to [...]

Dry eye disease (DED) is a ubiquitous disorder in patients who are candidates for corneal refractive surgery and implantation of premium intraocular lenses to treat presbyopia and cataracts, according to [...]

A recent Ophthalmology Times Grand Rounds panel in Miami Beach, Florida, discussed advanced solutions and achieving superior outcomes with durable treatments in patients with challenging retinal vascular diseases. The discussion [...]

Starting the treatment of dry eye disease early can be the most beneficial route, but nipping seemingly normal cases in the bud may be an art. During this Ophthalmology Times [...]

With the use of artificial intelligence (AI) growing exponentially in health care, it is important to determine just how accurate, safe, and usable the technology is in clinical practice. Kevin [...]

During a recent Ophthalmology Times EyeViewdiscussion, Margaret Chang, MD, MS, delved into the port delivery system (PDS) for ranibizumab (Susvimo; Genentech), covering implantation requirements, surgical training, and key considerations for [...]

In this Ophthalmology Times EyeView, John Doane, MD, FACS, offered insights into small incision lenticule extraction (SMILE) for patients with simple myopia and compound myopic astigmatism and discussed the latest [...]

In an Ophthalmology Times Insight roundtable discussion, Alice Epitropoulos, MD, and Laura M. Periman, MD, shared insights into their comprehensive approach to treating patients with dry eye symptoms. Epitropoulos is [...]

By Lynda Charters Artificial intelligence (AI) is finding its niche in medical research, with more and more applications being explored. A team of researchers in the United Kingdom (UK) are [...]

Knowing the approach to each step of ocular management can optimize patient vision. Reviewed by Selina McGee, OD, FAAO Achieving the best vision possible by managing existing dry eye disease [...]

Additional testing is needed to ensure accuracy across different groups. Machine learning (ML) seems to be the wave of the future in medicine and, when perfected, it will be a [...]

DED incidence rates vary markedly depending on the ophthalmic practice. Dry eye disease (DED) does not always exist in a vacuum. An expert panel--Marguerite B. McDonald, MD, FACS; Peter McDonnell, [...]

Anchored matching-adjusted indirect comparison may aid decision-making A study that indirectly compared the efficacy of 2 drugs evaluated in phase 3 trials using an anchored matching adjusted indirect comparison found [...]

Slit lamp evaluation can provide valuable information for treatment course. Managing patients diagnosed with dry eye disease may not be as clear-cut as it appears. Mile Brujic, OD, FAAO, a [...]

October 19, 2023 Developing technology may offer marked improvements in surgical precision Surgeons are becoming increasingly aware of the advantages of advanced technologies, such as digital microscopes and 3D visualization [...]

October 20, 2023 Collaborate between ophthalmologists, optometrists can boost early detection. Dry eye disease is ubiquitous and, if left untreated, it can substantially alter the ocular surface and further worsen [...]

October 25, 2023 Technology allows partitioning of sequencing reads into 2 parental genome data sets. Long-read sequencing technology may be emerging as an option to streamline haplotype analysis in cases [...]

Magnetic cell delivery of human corneal endothelial cells (HCECs) to the anterior chamber seems to be a safe cell-based treatment that is exhibiting early signs of efficacy for corneal endothelial [...]

Digitally guided systems, which relieve surgeons from using goniolenses, facilitate more accurate and faster performance of minimally invasive glaucoma surgery (MIGS) procedures by more surgeons. These benefits, in turn, translate [...]

In the Ophthalmology Times Case of the Quarter series, Katherine Talcott, MD, shared 2 cases of geographic atrophy (GA) and highlighted the importance of multimodal imaging to diagnose and monitor [...]

The SimVis Gekko eye dominance strength (EDS; 2EyesVision) test provides a new way for patients to choose the monovision correction in their IOLs and contact lenses that best suits them. [...]

The VS 2020 (Twenty/Twenty Therapeutics) is a novel virtual reality headset that can provide acceptable repeatability for assessing the pupillary response and ocular alignment among patients with cataracts, according to [...]

Commonly used immunosuppressants used in the short term to control an ocular inflammatory disease were not associated with increased risk of developing cancer later,1 according to the first study author [...]

News Article Optometry Times Journal November digital edition 2023 Volume 15 Issue 11 A multicenter study in Japan examined patients to understand geographic atrophy characteristics and progression rate. A Japanese [...]

Retinoblastoma is a rare childhood cancer caused by a mutation in the RB1 gene. Despite decades of research, there is still much to learn about the genetic makeup of the disease. The availability of treatment options varies by country, with underdeveloped countries having limited access to advanced therapies. Genetic testing plays a crucial role in understanding the inheritance and predisposition to retinoblastoma. Newer techniques, such as cell-free DNA analysis, offer promising alternatives for diagnosis and monitoring. Further research is needed to identify biomarkers and improve diagnostic and treatment options. [Extracted from the article]

Jun 20, 2023 Surgeons seek best IOL match for patients after cataract surgery. Matching patients to the correct lens is becoming an art because of the advances in technology, and [...]

Jul 5, 2023 Trainees learn to recognize key pathologies seen in fundus examinations, OCT images The COVID-19 pandemic interrupted every aspect of life and forced the creation of online methods [...]

Reviewed by Jason Bacharach, MD Preservative-free latanoprost 0.005% (Iyuzeh, latanoprost ophthalmic solution; Thea Pharma US) showed comparable IOP-lowering capabilities to the preserved latanoprost formulation (Xalatan; Pfizer) in patients with primary [...]

Reviewed by Robert Yu YP-P10 (Yuyu Pharma), a novel, patented synthetic peptide, is being evaluated for safety, tolerability, and efficacy in the phase 2 clinical trial ICECAP 1 (NCT05467293). Yuyu [...]